Initial COVID vaccine dose offers some protection, but not enough for 95% efficacy
Video Credit: KDVR - Duration: 01:32s - Published
Initial COVID vaccine dose offers some protection, but not enough for 95% efficacy
Officials say you have a good level of protection after receiving the first dose of the coronavirus vaccine, but not enough to reach its full efficacy.
U.K. Becomes First Country to Authorize
Oxford-AstraZeneca COVID-19 Vaccine.
On Wednesday, the United Kingdom gave emergency
authorization to the COVID-19 vaccine developed by the
University of..
Credit: Wibbitz Top Stories Duration: 01:25Published
Novavax COVID-19 Vaccine Becomes
5th to Reach Phase 3 Trial in the US.
On Monday, Novavax announced the beginning
of its Phase 3 trial for its vaccine candidate,
named NVX-CoV2373, in the U.S. and..
Credit: Wibbitz Top Stories Duration: 00:49Published
CBS 2's Chris Tye reports Governor Pritzker said there will be enough COVID vaccines for those getting shots this week to get the necessary second vaccine weeks later, despite being told by the federal..
![UK Becomes First Country to Authorize Oxford-AstraZeneca COVID-19 Vaccine [Video]](https://video.newsserve.net/300/v/20201230/1314856163-UK-Becomes-First-Country-to-Authorize-Oxford-AstraZeneca.jpg)
![Novavax COVID-19 Vaccine Becomes 5th to Reach Phase 3 Trial in the US [Video]](https://video.newsserve.net/300/v/20201230/1314851085-Novavax-COVID-19-Vaccine-Becomes-5th-to-Reach.jpg)
![Illinois Has Enough COVID Vaccine For Second Dose [Video]](https://video.newsserve.net/300/v/20201218/2012172354-Illinois-Has-Enough-COVID-Vaccine-For-Second-Dose.jpg)
